Peter Hillmen
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
- Genetics 33
- Chronic Lymphocytic Leukemia Research 26
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
- Immunology 28
- Complement system in diseases 18
- Immunodeficiency and Autoimmune Disorders 7
- Co-authors
- Stephen J. Richards (8 shared papers)Russell P. Rother (3 shared papers)Anita Hill (2 shared papers)Richard Kelly (3 shared papers)Mary Jane Cullen (1 shared paper)L Arnold (1 shared paper)Irene Roberts (1 shared paper)Ιoannis Kotsianidis (1 shared paper)
- Journals
- Blood (16 papers)Journal of Clinical Oncology (7 papers)Haematologica (4 papers)British Journal of Haematology (3 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter Hillmen
47 papers receiving 663 citations
Peers
Comparison fields: 5 of 62
- Genetics 192
- Nephrology 128
- Hematology 199
- Immunology 352
- Physiology 42
Countries citing papers authored by Peter Hillmen
This map shows the geographic impact of Peter Hillmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hillmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hillmen more than expected).
Fields of papers citing papers by Peter Hillmen
This network shows the impact of papers produced by Peter Hillmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hillmen. The network helps show where Peter Hillmen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hillmen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 170 | |
| 2 | 2010 | 154 | |
| 3 | 2009 | 94 | |
| 4 | 2000 | 59 | |
| 5 | 2015 | 34 | |
| 6 | 1992 | 15 | |
| 7 | 2006 | 13 | |
| 8 | 2006 | 12 | |
| 9 | 2006 | 12 | |
| 10 | 2006 | 10 | |
| 11 | 2013 | 10 | |
| 12 | 2000 | 8 | |
| 13 | 2006 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2021 | 7 | |
| 16 | Achieving a MRD negative response after alemtuzumab for CLL is the best predictor for prolonged survival | 2003 | 5 |
| 17 | 2023 | 4 | |
| 18 | The initial report of the bloodwise tap clarity study combining ibrutinib and venetoclax in relapsed, refractory Cll shows acceptable safety and promising early indications of efficacy. | 2017 | 4 |
| 19 | 2007 | 4 | |
| 20 | 2006 | 4 |
About Peter Hillmen
Peter Hillmen is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Hematology and Molecular Biology, having authored 50 papers that have together received 686 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Complement system in diseases (18 papers), Lymphoma Diagnosis and Treatment (12 papers), Blood groups and transfusion (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Renal Diseases and Glomerulopathies (4 papers). The work is most often cited by research in Genetics (192 citations), Nephrology (128 citations), Hematology (199 citations), Immunology (352 citations) and Physiology (42 citations). Peter Hillmen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stephen J. Richards, Russell P. Rother, Anita Hill, Richard Kelly, Mary Jane Cullen, L Arnold, Irene Roberts, Ιoannis Kotsianidis, D. Mark Layton and Yusuke Maeda. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, British Journal of Haematology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.